NASDAQ : SPRO

Spero Therapeutics, Inc.

$1.7 USD

$0 (0.0%)

Volume
1.41M
Average Volume
1.17M
Market Capitalization
$98.43M
P/E Ratio
6.30
Dividend Yield
0.00%
Price Target
Year High
$3.08
Year Low
$1.63
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$10.50

SPRO Estimated and Actual Revenue by Quarter

SPRO Estimated and Actual EPS by Quarter

SPRO Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2026-12-31 1 -166.62K -166.62K -166.62K -168.06K -168.06K -168.06K
2026-09-30 1 -152.46K -152.46K -152.46K -153.78K -153.78K -153.78K
2026-06-30 1 -139.52K -139.52K -139.52K -140.72K -140.72K -140.72K
2026-03-31 1 -127.66K -127.66K -127.66K -128.77K -128.77K -128.77K
2025-12-31 1 -12.87M -12.87M -12.87M -12.98M -12.98M -12.98M
2025-09-30 1 -5.94M -5.94M -5.94M -5.99M -5.99M -5.99M
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2026-12-31 1 -8.02M -8.02M -8.02M 1.04M 1.04M 1.04M
2026-09-30 1 -9.17M -9.17M -9.17M 950.84K 950.84K 950.84K
2026-06-30 1 -9.74M -9.74M -9.74M 870.08K 870.08K 870.08K
2026-03-31 1 -10.31M -10.31M -10.31M 796.18K 796.18K 796.18K
2025-12-31 1 -11.46M -11.46M -11.46M 80.24M 80.24M 80.24M
2025-09-30 1 -14.32M -14.32M -14.32M 37.03M 37.03M 37.03M
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2026-12-31 1 336.72K 336.72K 336.72K 1 -0.14 -0.14 -0.14
2026-09-30 1 308.12K 308.12K 308.12K 1 -0.16 -0.16 -0.16
2026-06-30 1 281.95K 281.95K 281.95K 1 -0.17 -0.17 -0.17
2026-03-31 1 258K 258K 258K 1 -0.18 -0.18 -0.18
2025-12-31 1 26M 26M 26M 1 -0.2 -0.2 -0.2
2025-09-30 1 12M 12M 12M 1 -0.25 -0.25 -0.25